| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 02/01/2000 | US6020145 Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96 |
| 02/01/2000 | US6020142 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 02/01/2000 | US6020141 Microplate thermal shift assay for ligand development and multi-variable protein chemistry optimization |
| 02/01/2000 | US6020140 Autoantibodies and their targets in the diagnosis of peripheral neuropathies |
| 02/01/2000 | US6020135 Monitoring expression of these genes is used to provide indications of p53 status in a cell. such monitoring can also be used to screen for useful anti-cancer therapeutics, as well as for substances which are carcinogenic. |
| 02/01/2000 | US6020134 Method for diagnosing cancer via DNA hybridization |
| 02/01/2000 | US6020132 Chimeric nucleic acids compounds that have the capacity of forming triplex structures. |
| 02/01/2000 | US6020127 Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy |
| 02/01/2000 | US6020123 Oligonucleotide sequences for the amplification of the genome of the retroviruses of the HIV-2 and SIV type, and their uses for in vitro diagnosis of the infections due to these viruses |
| 02/01/2000 | US6020122 Hepatitis C virus second envelope (HCV-E2) glycoprotein expression system |
| 02/01/2000 | US6020052 Laminated membrane structure for polarographic measurement and methods of making said structures |
| 02/01/2000 | US6019987 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 02/01/2000 | US6019980 Nucleic acid respiratory syncytial virus vaccines |
| 02/01/2000 | US6019972 Peptides of human T cell reactive feline protein (TRFP) |
| 02/01/2000 | US6019969 Composition comprising antibody to macrophage-derived inflammatory mediator (MIP-α 1 and MIP-1β) |
| 02/01/2000 | US6019944 Rely on the use of defined surfaces and capillarity alone or in various combinations to move the test reagents. |
| 02/01/2000 | US6019896 Method for using a quality metric to assess the quality of biochemical separations |
| 02/01/2000 | US6019879 Electrochemical gas sensor |
| 02/01/2000 | US6019735 Viscosity measuring apparatus and method of use |
| 02/01/2000 | US6019734 Patch impregnated with potassium hydroxide applied to carrier; ph detector |
| 02/01/2000 | US6019551 Extracting system and method |
| 02/01/2000 | US6019222 Apparatus and kit for examining a specimen |
| 02/01/2000 | US6019006 Centrifuges and associated apparatus and method |
| 02/01/2000 | US6019005 Automatic sampling apparatus for the farmer stock peanut pneumatic sampler |
| 02/01/2000 | US6018989 Method and apparatus for measuring the properties of a fiber or colloid suspension |
| 02/01/2000 | US6018985 Method and apparatus for measuring unattached radon progeny |
| 02/01/2000 | US6018983 Method and apparatus for matching refrigerants |
| 02/01/2000 | CA2218491C Novel methods for the assay of troponin i and t and complexes of troponin i and t and selection of antibodies for use in immunoassays |
| 02/01/2000 | CA2192212C Method and apparatus for calibrating moisture sensors |
| 02/01/2000 | CA2173904C A procedure for determining the type and quantity of a substance that can be converted electrochemically and that is contained in a gas sample |
| 02/01/2000 | CA2171982C Drug binding protein |
| 02/01/2000 | CA2132269C Interactive automated cytology method and system |
| 02/01/2000 | CA2105828C Apparatus for depositing and staining cytological material on a microscope slide |
| 02/01/2000 | CA2105492C Glutathione analogs and paralog panels comprising glutathione mimics |
| 02/01/2000 | CA2025203C Device for withdrawing samples from molten metals |
| 02/01/2000 | CA2009198C Monoclonal antibody for differentiating hiv-2 from hiv-1 seropositive individuals |
| 02/01/2000 | CA1340888C Vaccines and diagnostic assays for haemophilus influenzae |
| 02/01/2000 | CA1340887C Sialic acid glycosides, antigens, immunoadsorbents, and methods for thier preparation |
| 01/30/2000 | CA2244349A1 Protein fragment complementation assays for the detection of biological or drug interactions |
| 01/27/2000 | WO2000004391A2 Prostate cancer assays and related methods |
| 01/27/2000 | WO2000004390A2 Microdevices for screening biomolecules |
| 01/27/2000 | WO2000004389A2 Arrays of protein-capture agents and methods of use thereof |
| 01/27/2000 | WO2000004388A2 System for the quantification of platelet activation |
| 01/27/2000 | WO2000004386A2 Co2 sensor |
| 01/27/2000 | WO2000004385A1 Method for detecting proteins |
| 01/27/2000 | WO2000004384A1 Device and method for the determination of protein domain boundaries |
| 01/27/2000 | WO2000004383A2 Hiv group o positive control |
| 01/27/2000 | WO2000004382A1 Arrays of proteins and methods of use thereof |
| 01/27/2000 | WO2000004381A1 Screening device and method of screening an immunoassay test |
| 01/27/2000 | WO2000004380A1 Determination of ligands for proteins |
| 01/27/2000 | WO2000004363A2 System for testing properties of materials |
| 01/27/2000 | WO2000004185A1 Adenoviral based promoter assay |
| 01/27/2000 | WO2000004184A1 Bivalent binding molecules of 7 transmembrane g protein-coupled receptors |
| 01/27/2000 | WO2000004157A2 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | WO2000004152A2 Androgen receptor coactivators |
| 01/27/2000 | WO2000004151A2 Identification and characterization of splice variants of kappa3-related opioid receptor (kor3) gene |
| 01/27/2000 | WO2000004149A2 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | WO2000004140A1 71 human secreted proteins |
| 01/27/2000 | WO2000004052A2 Soluble derivatives of anti-angiogenic peptides |
| 01/27/2000 | WO2000004050A2 Neurotrophic growth factor |
| 01/27/2000 | WO2000004048A1 Peptides of il-2 and derivatives thereof and their use as therapeutic agents |
| 01/27/2000 | WO2000004041A2 Methods and molecules relating to cd39-like polypeptides |
| 01/27/2000 | WO2000004031A1 Phosphorous organic compounds and their use |
| 01/27/2000 | WO2000004007A1 Fluorescent dibenzazole derivatives and methods related thereto |
| 01/27/2000 | WO2000003739A1 (cag)/q expansion disorders |
| 01/27/2000 | WO2000003727A1 Engineered proteins for analyte sensing |
| 01/27/2000 | WO2000003725A1 Method for identifying and confirming consistent bio-functionality of natural compositions |
| 01/27/2000 | WO2000003711A1 Compounds and compositions for treating tissue ischemia |
| 01/27/2000 | WO2000003699A2 Drugs containing phosphoric acid derivatives as active ingredient and their use |
| 01/27/2000 | WO2000003687A2 Potassium channel polypeptide and polynucleotide compositions |
| 01/27/2000 | WO2000003640A1 Measuring nitric oxide concentration in tissue |
| 01/27/2000 | WO1999063930A3 Novel angiotensin receptor modulators and their uses |
| 01/27/2000 | WO1999063115A3 Use of cathepsin s in the diagnosis and treatment of endometriosis |
| 01/27/2000 | WO1999061589A3 Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof |
| 01/27/2000 | WO1999054465A9 Gene encoding syntaxin interacting protein |
| 01/27/2000 | WO1999049831A3 Amplified fluorescent materials and uses thereof |
| 01/27/2000 | DE19833547A1 Sensor system for oxidizable and reducible gases in driver's environment in vehicle, uses single sensor, and has processor which separates out signal components |
| 01/27/2000 | DE19831637A1 Identifying antiparasitic agents used to treat or prevent parasitic infections, especially malaria, sleeping sickness and leishmaniosis |
| 01/27/2000 | DE19831385A1 Hemodialysis parameter determination in kidney treatment, measuring parameters of dialysis fluid, obtaining transfer function for membrane, comparing with values from mathematical formulae |
| 01/27/2000 | DE19830405A1 Immunoassay test strip for detecting drugs, low molecular pollutants, etc. |
| 01/27/2000 | DE19826583A1 Method for measuring gaseous chemical constituents in process reactor serving for treatment of electrical components, measurements taking place in situ by means of at least one residual gas analysis unit communicating with process chamber |
| 01/27/2000 | CA2507754A1 Arrays of protein-capture agents and methods of use thereof |
| 01/27/2000 | CA2337997A1 Compounds and compositions for treating tissue ischemia |
| 01/27/2000 | CA2337835A1 Potassium channel polypeptide and polynucleotide compositions |
| 01/27/2000 | CA2337654A1 Arrays of proteins and methods of use thereof |
| 01/27/2000 | CA2337511A1 Peptides of il-2 and derivatives thereof and their use as therapeutic agents |
| 01/27/2000 | CA2337444A1 Screening device and method of screening an immunoassay test |
| 01/27/2000 | CA2337362A1 Cloning and characterisation of novel mammalian peptidases |
| 01/27/2000 | CA2337353A1 Device and method for the determination of protein domain boundaries |
| 01/27/2000 | CA2337075A1 Arrays of protein-capture agents and methods of use thereof |
| 01/27/2000 | CA2336219A1 Identification and characterization of multiple splice variants of the kappa3-related opioid receptor (kor-3) gene |
| 01/27/2000 | CA2336143A1 Aminoalkylphosphonic acid derivatives and their use in treating infections |
| 01/27/2000 | CA2335101A1 Androgen receptor coactivators |
| 01/27/2000 | CA2335096A1 Methods and materials relating to novel cd39-like polypeptides |
| 01/27/2000 | CA2334045A1 Adenoviral based promoter assay |
| 01/27/2000 | CA2334038A1 Compositions and methods for therapy and diagnosis of prostate cancer |
| 01/27/2000 | CA2333929A1 Soluble derivatives of anti-angiogenic peptides |
| 01/27/2000 | CA2333917A1 71 human secreted proteins |
| 01/27/2000 | CA2333910A1 Neurotrophic growth factor |
| 01/27/2000 | CA2333471A1 Human scad-related molecules, scrm-1 and scrm-2 |